FDA product code JPA: System, Multipurpose For In Vitro Coagulation Studies

JPA is the FDA product code for system, multipurpose for in vitro coagulation studies. It is a Class II device, regulated under 21 CFR 864.5425 and reviewed by the Hematology panel. FDA has cleared 182 510(k) submissions under JPA, 10 in the last five years, from 68 different applicants. The average 510(k) review took 119 days (median 81); 165 days on average over the last three years. FDA has posted 44 recalls for JPA devices, 7 initiated in the last five years.

Classification

FieldValue
Device nameSystem, Multipurpose For In Vitro Coagulation Studies
Device classClass II
Regulation21 CFR 864.5425
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for JPA

YearClearancesAvg. review days
20174171
20181219
20193152
20211518
20221767
20233410
20241266
2025340
20262190

Compare with all 510(k) review times · Search every JPA clearance

Top JPA applicants

ApplicantClearancesLatest
Bio/Data Corp.131989-06-23
Dade Behring, Inc.122003-01-16
Instrumentation Laboratory CO112023-09-29
International Technidyne Corp.92005-02-10
Helena Laboratories82006-05-10

63 more applicants have JPA clearances. See the full list in Caduvo.

Most recent JPA clearances

510(k)ApplicantDeviceDecision dateReview days
K260909Sienco, Inc.Sonoclot Coagulation & Platelet Function Analyzer System with Sonoclot Viewer (SCP1); Sonoclot Coagulation & Platelet Function Analzyer System with Sonoclot Viewer (SCP2); Sonoclot Coagulation Analyzer System with Sonoclot Viewer (SC1)2026-10-27222
K253658Diagnostica Stago, Inc.STA Satellite Max®2026-04-27158
K250965Sysmex America, Inc.Automated Blood Coagulation Analyzer CN-Series (CN-6000)2025-06-0263
K251024HaemoneticsTEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge2025-04-3028
K243858Haemonetics CorporationTEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge2025-01-1530

Recalls for JPA devices

44 product recalls in 32 recall events; 7 initiated in the last five years and 6 still open. Most recent: 2026-09-14.

YearRecalls
20193
20202
20211
20222
20233
20251
20261

Frequently asked questions

What is FDA product code JPA?

JPA is the FDA product code for system, multipurpose for in vitro coagulation studies. It is a Class II device, regulated under 21 CFR 864.5425 and reviewed by the Hematology panel.

What device class is JPA?

Class II, regulation 21 CFR 864.5425. Typical premarket route: 510(k).

How long does a 510(k) take for product code JPA?

Across 182 cleared submissions the average was 119 days from receipt to decision (median 81).

Which companies have the most JPA clearances?

Bio/Data Corp. (13); Dade Behring, Inc. (12); Instrumentation Laboratory CO (11); International Technidyne Corp. (9); Helena Laboratories (8).

Have JPA devices been recalled?

Yes: 44 product recalls across 32 recall events; the most recent began 2026-09-14.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times